vs

Side-by-side financial comparison of REPLIGEN CORP (RGEN) and WORTHINGTON ENTERPRISES, INC. (WOR). Click either name above to swap in a different company.

WORTHINGTON ENTERPRISES, INC. is the larger business by last-quarter revenue ($327.5M vs $197.9M, roughly 1.7× REPLIGEN CORP). WORTHINGTON ENTERPRISES, INC. runs the higher net margin — 8.3% vs 6.7%, a 1.6% gap on every dollar of revenue. On growth, WORTHINGTON ENTERPRISES, INC. posted the faster year-over-year revenue change (19.5% vs 13.6%). WORTHINGTON ENTERPRISES, INC. produced more free cash flow last quarter ($39.1M vs $17.6M).

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

Worthington Enterprises, Inc. is an American industrial manufacturing company headquartered in Columbus, Ohio. The company is composed of two business segments, consumer products and building products. Within these segments, the company designs and manufactures pressure vessels such as propane, oxygen and helium tanks, refrigerant and industrial cylinders, camping and residential use cylinders, water system tanks for storage, treatment, heating, expansion and flow control, as well as a variet...

RGEN vs WOR — Head-to-Head

Bigger by revenue
WOR
WOR
1.7× larger
WOR
$327.5M
$197.9M
RGEN
Growing faster (revenue YoY)
WOR
WOR
+5.8% gap
WOR
19.5%
13.6%
RGEN
Higher net margin
WOR
WOR
1.6% more per $
WOR
8.3%
6.7%
RGEN
More free cash flow
WOR
WOR
$21.5M more FCF
WOR
$39.1M
$17.6M
RGEN

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
RGEN
RGEN
WOR
WOR
Revenue
$197.9M
$327.5M
Net Profit
$13.3M
$27.3M
Gross Margin
52.5%
25.8%
Operating Margin
9.0%
3.7%
Net Margin
6.7%
8.3%
Revenue YoY
13.6%
19.5%
Net Profit YoY
143.9%
-3.3%
EPS (diluted)
$0.24
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGEN
RGEN
WOR
WOR
Q4 25
$197.9M
$327.5M
Q3 25
$188.8M
$303.7M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
RGEN
RGEN
WOR
WOR
Q4 25
$13.3M
$27.3M
Q3 25
$14.9M
$35.1M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
RGEN
RGEN
WOR
WOR
Q4 25
52.5%
25.8%
Q3 25
53.2%
27.1%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
RGEN
RGEN
WOR
WOR
Q4 25
9.0%
3.7%
Q3 25
8.9%
3.0%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
RGEN
RGEN
WOR
WOR
Q4 25
6.7%
8.3%
Q3 25
7.9%
11.6%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
RGEN
RGEN
WOR
WOR
Q4 25
$0.24
$0.55
Q3 25
$0.26
$0.70
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGEN
RGEN
WOR
WOR
Cash + ST InvestmentsLiquidity on hand
$767.6M
$180.3M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$2.1B
$962.6M
Total Assets
$2.9B
$1.8B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGEN
RGEN
WOR
WOR
Q4 25
$767.6M
$180.3M
Q3 25
$748.7M
$167.1M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
RGEN
RGEN
WOR
WOR
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RGEN
RGEN
WOR
WOR
Q4 25
$2.1B
$962.6M
Q3 25
$2.1B
$959.1M
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
RGEN
RGEN
WOR
WOR
Q4 25
$2.9B
$1.8B
Q3 25
$2.9B
$1.7B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
RGEN
RGEN
WOR
WOR
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGEN
RGEN
WOR
WOR
Operating Cash FlowLast quarter
$25.7M
$51.5M
Free Cash FlowOCF − Capex
$17.6M
$39.1M
FCF MarginFCF / Revenue
8.9%
11.9%
Capex IntensityCapex / Revenue
4.1%
3.8%
Cash ConversionOCF / Net Profit
1.93×
1.89×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGEN
RGEN
WOR
WOR
Q4 25
$25.7M
$51.5M
Q3 25
$48.1M
$41.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
RGEN
RGEN
WOR
WOR
Q4 25
$17.6M
$39.1M
Q3 25
$43.4M
$27.9M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
RGEN
RGEN
WOR
WOR
Q4 25
8.9%
11.9%
Q3 25
23.0%
9.2%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
RGEN
RGEN
WOR
WOR
Q4 25
4.1%
3.8%
Q3 25
2.5%
4.3%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
RGEN
RGEN
WOR
WOR
Q4 25
1.93×
1.89×
Q3 25
3.23×
1.17×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RGEN
RGEN

Segment breakdown not available.

WOR
WOR

Building Products$207.5M63%
Equity Method Investment Nonconsolidated Investee Other$120.7M37%

Related Comparisons